The proliferation of the positive Covid19 cases in the United States has compelled the country to order a sold out purchase of the anti-viral drug remdesivir, thereby exhausting all available global supplies for the next three months.
The anti-viral remdesivir drug is one of two drugs that have proven to be effective for the treatment of Covid19.
The US Department of Health Services (HHS) announced on Monday it had secured more than 500,000 treatment courses of remdesivir from drugmaker Gilead Sciences for US hospitals until September.
The stocks make up 100 percent of Gilead’s projected production for July and 90 percent each for August and September.
“President [Donald] Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for COVID-19,” HHS Secretary Alex Azar said in a statement.
“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it.”
Remdesivir, which is administered intravenously in hospital, is the first drug to show improvement in COVID-19 patients in formal clinical trials, and new information about its efficacy is being closely watched around the world, as nations battle the coronavirus pandemic.
Source: Aljazeera
Comments are closed.